MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 100 filers reported holding MARINUS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $9,077,000 | +41.5% | 907,732 | 0.0% | 0.24% | +44.6% |
| Q2 2018 | $6,417,000 | +85.1% | 907,732 | 0.0% | 0.17% | +73.2% |
| Q1 2018 | $3,467,000 | -53.2% | 907,732 | 0.0% | 0.10% | -60.6% |
| Q4 2017 | $7,407,000 | -56.6% | 907,732 | -68.8% | 0.25% | -24.5% |
| Q3 2017 | $17,054,000 | – | 2,905,400 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 1,192,883 | $15,329,000 | 3.00% |
| Bain Capital Life Sciences Investors, LLC | 1,431,059 | $18,389,000 | 1.71% |
| Avoro Capital Advisors LLC | 3,000,000 | $38,550,000 | 0.55% |
| Palo Alto Investors LP | 31,330 | $403,000 | 0.02% |